EUVIMEDEUVIMED entdecken
Open Access

Integrative network pharmacology and experimental study of Qingda granule in hypertension-induced endothelial dysfunction

Yanyan Yang, Qiurong Xie, Jingyi Zeng, Meizhu Wu, Daxin Chen, Wenqiang Zhang, Chenyu Lai, Aling Shen, Dawei Lian, Jun Peng

Experimental Animals · 2025

DOI: 10.1538/expanim.25-0080 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Experimental Animals, 2025. Verfasst von Yanyan Yang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Academy of Integrative Medicine, Fujian University of Traditional Chinese Medicine, No. 1 Qiuyang Road, Fuzhou, Fujian, 350122, P.R. China. Hauptthemen laut MEDLINE: Hypertension, Drugs, Chinese Herbal, Network Pharmacology, Endothelium, Vascular. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Endothelial dysfunction (ED) plays a pivotal role in the pathogenesis of hypertension and its associated vascular complications. Qingda granule (QDG) exhibits significant antihypertensive properties and demonstrates therapeutic potential in ameliorating vascular dysfunction. This study aimed to explore QDG's role in alleviating endothelial injury in hypertension. An L-NAME (Nω-Nitro-L-arginine methyl ester)-induced hypertensive mouse model was used to evaluate the effects of QDG on blood pressure and endothelial function. Endothelial function was assessed through histological analysis, nitric oxide (NO) quantification, and vascular response measurements. To explore underlying mechanisms, network pharmacology was conducted using databases such as HERB, SwissTargetPrediction and STRING. Key pathways related to inflammation and cell adhesion were identified. Based on these findings, immunohistochemical staining was conducted to analyze the expression of phosphorylation of nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB) p65 (p-NF-κB p65), NF-κB p65, intercellular adhesion molecule-1 (ICAM-1), and tumor necrosis factor-α (TNF-α) in vascular tissues. QDG treatment significantly reduced blood pressure, increased NO levels, and enhanced endothelial nitric oxide synthase (eNOS) expression in L-NAME-induced hypertensive mice, indicating its potential to restore endothelial function. Experimental validation further confirmed that QDG markedly suppressed the expression of p-NF-κB p65, TNF-α, and ICAM-1 in vascular tissues. These results suggest that QDG alleviates hypertension-induced ED primarily by inhibiting inflammation and endothelial adhesion via the NF-κB signaling pathway. Overall, QDG presents a promising therapeutic candidate for managing hypertension and its vascular complications.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HypertensionDrugs, Chinese HerbalNetwork PharmacologyEndothelium, VascularAntihypertensive AgentsAnimalsMaleDisease Models, AnimalMice, Inbred C57BLNitric OxideMiceBlood PressureNitric Oxide Synthase Type IIING-Nitroarginine Methyl EsterIntercellular Adhesion Molecule-1

Stichwörter der Autor:innen

NF-κB signalingQingda granuleendothelial dysfunctionhypertensionvascular inflammation

Substanzen

Drugs, Chinese HerbalNitric OxideNitric Oxide Synthase Type IIING-Nitroarginine Methyl EsterIntercellular Adhesion Molecule-1Antihypertensive Agents

Autor:innen und Institutionen

  • Academy of Integrative Medicine, Fujian University of Traditional Chinese Medicine, No. 1 Qiuyang Road, Fuzhou, Fujian, 350122, P.R. China.
  • College of Integrative Medicine, Fujian University of Traditional Chinese Medicine, No. 1 Qiuyang Road, Fuzhou, Fujian, 350122, P.R. China.
  • Innovation and Transformation Center, Fujian University of Traditional Chinese Medicine, No. 1 Qiuyang Road, Fuzhou, Fujian, 350122, P.R. China.
  • Fujian Key Laboratory of Integrative Medicine on Geriatrics, Fujian University of Traditional Chinese Medicine, No. 1 Qiuyang Road, Fuzhou, Fujian, 350122, P.R. China.
  • Fujian Collaborative Innovation Center for Integrative Medicine in Prevention and Treatment of Major Chronic Cardiovascular Diseases, No. 1 Qiuyang Road, Fuzhou, Fujian, 350122, P.R. China.
  • College of Pharmacy, Fujian University of Traditional Chinese Medicine, No. 1 Qiuyang Road, Fuzhou, 350122, P.R. China.

Zitieren

APA

Yang, Y., Xie, Q., Zeng, J., Wu, M., Chen, D., Zhang, W., Lai, C., Shen, A., Lian, D., & Peng, J. (2025). Integrative network pharmacology and experimental study of Qingda granule in hypertension-induced endothelial dysfunction. Experimental Animals. https://doi.org/10.1538/expanim.25-0080

Vancouver

Yang Y, Xie Q, Zeng J, Wu M, Chen D, Zhang W, et al. Integrative network pharmacology and experimental study of Qingda granule in hypertension-induced endothelial dysfunction. Experimental Animals. 2025. doi:10.1538/expanim.25-0080

BibTeX
@article{Yang2025,
  author = {Yang, Yanyan and Xie, Qiurong and Zeng, Jingyi and Wu, Meizhu and Chen, Daxin and Zhang, Wenqiang and Lai, Chenyu and Shen, Aling and Lian, Dawei and Peng, Jun},
  title = {Integrative network pharmacology and experimental study of Qingda granule in hypertension-induced endothelial dysfunction},
  journal = {Experimental Animals},
  year = {2025},
  doi = {10.1538/expanim.25-0080}
}
Kostenlos starten →